Skip to main content

Business

12 articles · Latest business news, analysis, and reporting.

More in Business

Scientists Begin First Human Trial of Cellular Reprogramming to Reverse Aging

Nature reported on June 9 that the first participant has been treated in a human trial of cellular reprogramming. Life Biosciences, co-founded by Harvard professor David Sinclair, received FDA clearance in January 2026 for its partial epigenetic reprogramming therapy ER-100.